Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Conventional treatment versus botulinum toxin A for muscular temporomandibular disorder
RBR-2d4vvvCompleted
- Sponsor
- Faculdade de Odontologia de Piracicaba
- Start
- Apr 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label trial of botulinum toxin type A in temporomandibular disorder (TMD) (3 arms), sponsored by Faculdade de Odontologia de Piracicaba. Started Apr 2014; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
temporomandibular disorder (TMD)
Beyond the preview
Go deeper on RBR-2d4vvv.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-2d4vvv.